AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 110 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,153,000 | +17.7% | 109,734 | +17.4% | 0.01% | +25.0% |
| Q3 2016 | $3,528,000 | +113.9% | 93,490 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $1,649,000 | +82.8% | 93,699 | +26.4% | 0.00% | +100.0% |
| Q1 2016 | $902,000 | -49.4% | 74,148 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $1,783,000 | +37.2% | 73,218 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,300,000 | -0.2% | 73,265 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $1,303,000 | +36.7% | 73,851 | +142.9% | 0.00% | +100.0% |
| Q1 2015 | $953,000 | +8.9% | 30,401 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $875,000 | +38.2% | 29,965 | -2.0% | 0.00% | 0.0% |
| Q3 2014 | $633,000 | -15.3% | 30,576 | +1.3% | 0.00% | 0.0% |
| Q2 2014 | $747,000 | +56.6% | 30,177 | +33.9% | 0.00% | 0.0% |
| Q1 2014 | $477,000 | +34.7% | 22,533 | +14.2% | 0.00% | 0.0% |
| Q4 2013 | $354,000 | – | 19,727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |